Navigation Links
Kidney stone surgery: More women, more complications with minimally invasive procedure
Date:3/26/2013

DETROIT While the number of people especially women who have a minimally invasive procedure to remove kidney stones has risen in recent years, so has the rate of complications related to the surgery, according to a published study by Henry Ford Hospital.

The research, from Khurshid R. Ghani, M.D., of Henry Ford Hospital's Vattikuti Urology Institute, appears in the current issue of Journal of Urology.

The focus of the investigation was the procedure, percutaneous nephrolithotomy, or PCNL, in which a surgeon removes medium to large kidney stones through a small incision in the back using a hollow scope.

Minimally invasive procedures used for treating a wide range of medical conditions have increased in recent years, and the Henry Ford researchers set out to find how much and to what effect this is true for this specific procedure.

"What we found is that the use of PCNL in this country has increased," Dr. Ghani said, "and more women than men have the procedure.

"We also discovered that while the rate of PCNL-related death is low and has remained so, incidence of blood infection and overall complications has increased."

The population-based study looked at data from the Nationwide Inpatient Sample, a database of inpatient hospital stays used by researchers to find, track and analyze national health care trends. The database catalogs some 8 million cases from more than 1,000 hospitals in 44 states.

It was used in this study to identify patients who underwent PCNL between 1999 and 2009. A weighted sample was then formulated to estimate utilization rates across the country.

In addition, Henry Ford researchers tracked and analyzed trends in patient age; complications before, during and after the procedure; other disorders or diseases that existed at the time of the surgery; and in-hospital deaths.

A total of 80,097 patients over the age of 18 and with a median age of 53 were found to have undergone PCNL during the study period, during which the number of times the procedure was performed climbed by 47 percent.

The results showed:

  • PCNL use rose from 3.0 to 3.63 per 100,000 men, and from 2.99 to 4.07 per 100,000 women during the study period. This represented a 0.03 percent increase in men who underwent the procedure compared to a 2.54 percent increase in women.

  • Co-morbidity, or the presence of other disorders or disease at the time of surgery, increased during the study time-span.

  • At the same time, overall complications increased from 12.2 percent in 1999 to 15.6 percent in 2009.

  • Significantly, the incidence of sepsis or blood infection doubled, rising from 1.2 percent to 2.4 percent.

  • The rate of PCNL-related death remained essentially unchanged at 0 to 0.4 percent.

Dr. Ghani and his associates concluded that patients were at higher risk of developing complications if they were older, sicker and treated in more recent years. And though the rate of deaths associated with the procedure remained statistically flat, those cases that did occur were found with older patients.

"We believe the broad use of this procedure, especially in older and sicker patients, may be the reason for these changes," Dr. Ghani said.


'/>"/>
Contact: Dwight Angell
dwight.angell@hfhs.org
313-850-3471
Henry Ford Health System
Source:Eurekalert

Related medicine news :

1. d'Oliveira & Associates Releases New Byetta Infographic on Potential Kidney and Pancreas Health Risks Associated with the Drug
2. BIDMC investigator James Mier, M.D., awarded prominent grant for kidney cancer research
3. High-Dose Statins Linked to Acute Kidney Damage
4. New study points to the aggressive potential of small kidney tumors, advocates treatment
5. New Method Quickly Spots Kidney Damage After Surgery
6. Blacks With Kidney Disease Should Watch for Blood Pressure Shifts: Study
7. More U.S. Kidney Exchanges Would Allow 1,000 Additional Transplants Yearly
8. After years of growth, fewer transplants done through kidney chains
9. Trio of biomarkers may help identify kidney cancer in early stages
10. Kidney Disease Diet
11. How “Kidney Diet Secrets” Helps People Get Rid Of Their Kidney Disease Permanently – Health Review Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/18/2017)... New York (PRWEB) , ... ... ... Courier, LLC, d/b/a Quick International, LLC (“Quick”), a highly specialized asset-light logistics ... it has entered into a definitive agreement to purchase Unitrans International Corporation, ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces ... active, healthy lifestyles and highlighting the importance of proactive eye and ear health. ... shares the latest innovations in hearing aid technology. , In this issue, ...
(Date:8/18/2017)... ... August 18, 2017 , ... ... and financial consultations to communities throughout the greater DC region, is inaugurating a ... goal of rescuing local animals and training them to be companions for veterans ...
(Date:8/18/2017)... ... August 18, 2017 , ... MLM ... that serves communities throughout southern Florida, is working to support the Take Stock ... children from low income families. , The Take Stock In Children Foundation (TSC) ...
(Date:8/18/2017)... Bedford, TX (PRWEB) , ... August 18, 2017 , ... ... serves communities in the Dallas/Fort Worth area, is spearheading a regional charity campaign organized ... her husband. , In early June of this year, Christina and her children returned ...
Breaking Medicine News(10 mins):
(Date:7/28/2017)... 2017 Hill-Rom Holdings, Inc. ("Hill-Rom") (NYSE: HRC), ... ended June 30, 2017, and updated its financial outlook ... For the fiscal third quarter, Hill-Rom reported earnings ... diluted share in the prior-year period. These results reflect ... diluted share primarily related to the non-cash write-down of ...
(Date:7/27/2017)... July 27, 2017  West Pharmaceutical Services, Inc. (NYSE: ... for the second-quarter 2017 and updated financial guidance for ... Second-Quarter 2017 Highlights Reported net sales ... the prior-year quarter. Net sales at constant currency (organic) ... EPS was $0.51, compared to $0.60 in the prior-year ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals Company, ... our clinical trial evaluating Altemia TM , an oral ... and Sickle Cell Disease (SCD). The SCOT Trial, is ... efficacy and safety of Altemia TM in pediatric ... under US IND 125274. ...
Breaking Medicine Technology: